å»è¬åå ¬è¡šãããæŽå¯
ããªãªã¯ã¯ãã³ åžå ŽèŠæš¡ãšäºæž¬ â 2026 â 2033幎äžçã®ããªãªã¯ã¯ãã³ åžå ŽèŠæš¡ã¯è©äŸ¡ããããšæšå®ããã 2026幎ã®USD 4.5åãUSD 7.2åã«éããèŠèŸŒã¿ 2033幎ã2026幎6.3%ã®ååç©å¹Žéæé·ç(CAGR)ãåºå± 2033幎é ãããã£ãŒã«Polioã¯ã¯ãã³åžå Žã¯äž»ã«2ã€ã®äž»èŠãªè£œåã§æ§æãããŠããŸã ã¿ã€ã: ç¡å¹å ããªãªã¯ã¯ãã³ (IPV) ããã³çµå£ããªãªã¯ã¯ãã³(OPV)ã IPVã管çããã æ³šå ¥ã«ãã£ãŠãäžæŽ»æ§ã®ããªãªãŠã€ã«ã¹ãå«ã¿ãã§åºãå©çšãããŠããŸã 匷åãªå®å šãããã¡ã€ã«ã«ãã宿çãªå ç«ããã°ã©ã ã OPVã®ã å£é ã§ãæ¿ããã©ã€ããŠã€ã«ã¹... ãã£ãšèŠã
è³è «çåžå Žãé©å¿çå¥ïŒç¥çµè èœè «ãé«èè «ãäžåäœè «çããã®ä»ïŒåžçªèµ·è è «ãæç¶çްèè «ãªã©ïŒïŒãæ²»çã¿ã€ãå¥ïŒååŠçæ³ïŒã«ã«ã ã¹ãã³ããã¢ãŸããããé åå€ïŒãã ã¹ãã³ãããã«ã«ããžã³ããã³ã¯ãªã¹ãã³ïŒïŒïŒãæšççæ³ïŒããã·ãºãããã©ããã¬ã¯ãããã ãšã³ãã¬ã¯ãããããã®ä» (ãžãããã·ãããããã·ã¿ãã-gqgk ãªã©))ãå ç«çæ³ (ãã¹ã¿ãŒãªãããé¡ç²çãã¯ããã¡ãŒãžã³ãããŒåºæ¿å åããã³ãããªãºãã))ãæµéãã£ãã«å¥ (ç é¢è¬å±ãå°å£²è¬å±ããªã³ã©ã€ã³è¬å±)ãå°åå¥ (åç±³ããšãŒããããã¢ãžã¢å€ªå¹³æŽãã©ãã³ã¢ã¡ãªã«ãäžæ±ãã¢ããªã«)... ãã£ãšèŠã
æœ°çæ§å€§è žçã¯ãççã«åãŒãççæ§è žçŸæ£ã®ã«ããŽãªã§ãããæ¶å管ã®çã¿ã æœ°çæ§é¢ç¯çã¯ã倧ããªè ž(ã³ãã³)ãšç©åœ¢ã®å åŽã®ã©ã€ãã³ã°ã«åœ±é¿ãäžããŸãã éåžžãççã®éç床ã«å¿ããŠçç¶ãåŸã ã«èŠãããŸãã è¬ç©çæ³ã«ãã£ãŠè»œåºŠã®åŸŽåã¯æ²»ãããšãã§ããŸãããéçã®å Žåã«ã¯å€ç§åŠçœ®ã¯å¿ èŠã§ãã æœ°çæ§å€§è žçã¯ã8幎以äžã«ããã£ãŠæç¶ããå Žåãå€§è žããã«ã€ãªããå¯èœæ§ããããŸãã ãã«ã¹ã±ã¢äºé²çãå¢å ãããããšã«ãããæ²»çã®å©ç¹ãæ±ããããã«ããŸããŸããŸãææã«ãªã£ãŠããŠããŸãã äºé²å»çã§ã¯ãè¬ç©ãæ°èŠæ²»çããå€§è žããã®çºçå¯èœæ§ãäœäžãããŸãã é¢é£ããå䜵çã®å¯èœæ§ æœ°çæ§é¢ç¯ç 穎ããããã³... ãã£ãšèŠã
è¡åŸã¹ãã¬ã¹é害(PTSD)ã¯ãèªç¶çœå®³ãæ·±å»ãªäºæ ãæ§çæŽåãããè¡çºãªã©ãçµéšãŸãã¯èšŒäººçã€ãã³ãã«ãã£ãп޻æ§åããã粟ç¥çå¥åº·ç¶æ ã§ãã PTSDã¯ãå šãŠã®å¹Žéœ¢ã®äººã ã«çºçããå¯èœæ§ããããŸãã è¡åŸã®ã¹ãã¬ã¹é害ã®äž»ãªçç¶ã®ããã€ãã¯ãæèãšæ°åã®åŠå®çãªå€åããªãã³ã«ææ çããã³ç©ççåå¿ã®å€åã«äžå¯æ¬ ã§ãã PTSDã®å»åž«ã«ãã£ãŠåŠæ¹ãããäžè¬çãªè¬ã¯ãæãã€è¬ãæäžå®è¬ããã«ãªãã»ãã³ãªã©ã§ãã2022幎(2022幎ïœ2030幎)ã¯ãã°ããŒãã«ãã¹ãã»ãã©ãŠãããã¯ã»ã¹ãã¬ã¹ã»ãã£ã¹ãªãŒããŒã»ããªãŒãã¡ã³ãã»ããŒã±ãããç±³åœ$ 1034.3åã§è©äŸ¡ãããäºæž¬æé(2022幎ïœ20... ãã£ãšèŠã
ããšãã³ç åC(NPC)ã¯ããªãœãã«è²¯èµé害ã®äžçš®ã§ãããŸããªéºäŒçé害ã§ãã NPCã¯ãè³ãªã©ã®äœã®ç°ãªãçµç¹ã«ãããã³ã¬ã¹ãããŒã«ãä»ã®èèªç©è³ªã®èç©ã«ã€ãªããã NPCã®ç¹å®ã®çç¶ã®çºçã¯äººãã人ãŸã§æ§ã ã§ãã ã»ãšãã©ã®å Žåãçç¶ã¯å°å æã«çŸããŸããããã«ãããé«éœ¢åã«äŒŽãçæŽ»ãè ããå䜵çãåŒãèµ·ãããŸãã NPC 㯠NPC 1 éºäŒåãš NPC 2 éºäŒåã®å€ç°ã®çµæãšããŠçºçããèªåååž°çã«ç¶æ¿ãããŸããã°ããŒãã«ããšãã³ç è¬Cåæ²»ç åžå Ž - ã³ãããŠã€ã«ã¹ã®åœ±é¿(COVID-19)ãã³ãããã¯ã³ãããŠã€ã«ã¹(COVID-19)çºçã¯ã2019幎12æ31æ¥ãæŠæŒ¢ãäžåœã§æå... ãã£ãšèŠã
ãŸã©ããã¯ã¹åžå Žã補åã¿ã€ãå¥ïŒãŸã©ããã¯ã¹ 3.6 mg ããã³ãŸã©ããã¯ã¹ 10.8 mgïŒãçšé/é©å¿çå¥ïŒåç«è ºãããä¹³ãããåå®®å èçãææ¥ææ©çºçããã®ä»ã®ãã«ã¢ã³æåæ§çŸæ£ïŒããšã³ããŠãŒã¶ãŒå¥ïŒç é¢ãè «çç§ã¯ãªããã¯ãå°éæ²»çã»ã³ã¿ãŒãç ç©¶ããã³åŠè¡æ©é¢ïŒãå°çå¥ïŒåç±³ããšãŒããããã¢ãžã¢å€ªå¹³æŽãã©ãã³ã¢ã¡ãªã«ãäžç±³ïŒ æ±éšãã¢ããªã«)... ãã£ãšèŠã
ã³ãã³ã¯ã¬ã³ãºåžå Žã補åã¿ã€ãå¥ïŒããŒãçµè žæŽæµå€ãç¹ç¶ããŒã¹ã®æŽæµå€ããããã€ãªãã£ã¯ã¹ãµããªã¡ã³ããæµ£è žããã³æŽæµããããªã©ïŒã圢æ å¥ïŒé å€ããã³ã«ãã»ã«ãç²æ«ããã³é£²ææ··åç©ãããã³æ¶²äœæº¶æ¶²ïŒãçšéå¥ïŒå人ãç é¢ããã³ãŠã§ã«ãã¹æœèšããã³æœèšïŒãæµéãã£ãã«å¥ïŒãªã³ã©ã€ã³å°å£²ãè¬å±ããã³ãã©ãã°ã¹ãã¢ãã¹ãŒããŒããŒã±ããããã³ãã®ä»ïŒ ãã€ããŒããŒã±ãããããã³å°éå»çåº)ããšã³ããŠãŒã¶ãŒ (æäºº (18 ïœ 45 æ³)ãäžå¹Ž (46 ïœ 65 æ³)ãããã³é«éœ¢è (65 æ³ä»¥äž))ãå°çå¥ (åç±³ããšãŒããããã¢ãžã¢å€ªå¹³æŽãã©ãã³ã¢ã¡ãªã«ãäžæ±ãããã³ã¢ããªã«)... ãã£ãšèŠã
泚å°å¯èœãªè¬å€ã®é éã·ã¹ãã ã¯ããã£åœ¢æãç®ã®ãã€ãç· ãŸãããšããã³ããã®åŠçœ®ã®ãããªå¯©çŸçãªåŠçœ®ã«äœ¿çšãããŸãã æ°ããªæ²»çæ³ã®éžæè¢ãšããŠãå»çæè¡ã®é²æ©ãšããŠãçèå ãéèå ãããã³ç®äžã®ãããªæ£è ã®äœã«å ¥ãããã®ããŸããŸãªç®¡çã«ãŒãããããŸãã ããã€ãã®æçç©è³ªãæ¶²äœè¬ãããã³ç¡¬åäºé²æ¥çš®ã®ç ç©¶ãšéçºã®ãã ã¢ã¯ã»ãµãªãŒ é«åºŠãªå»çæè¡ã«å€§ããªæè³ãããŠããŸããç±³åœé£åå»è¬åå±ã«ãããšãè¬ç©ããã³ã¯ã¯ãã³ã®97%ã¯æ³šå°ãéããŠæäžãããã äž»èŠãªæ³šå°è¬ã¯ãã©ãžã«ã®remicadeãavastinãneulastaãrituxanãçãå«ãã§ããŸãããã©ãžã«ã®æ³šå°è¬ã¯ãç é¢ãè¡ç®¡ã®æ§æ... ãã£ãšèŠã
ãããã©ãããŒã«åžå Žã補åã¿ã€ãå¥ïŒå³ææŸåºåãããã©ãããŒã«ãåŸæŸæ§ïŒåŸæŸïŒãããã©ãããŒã«ã泚å°çšãããã©ãããŒã«ïŒãçšé匷床å¥ïŒ20 ïœ 40 mgã60 ïœ 80 mgã10 mg ãŸã§ãããã³ 100 mg 以äžïŒãé©å¿çå¥ïŒé«è¡å§ãçå¿çã äžæŽèãçé çã®äºé²ãäžå®é害ïŒããã©ãŒãã³ã¹/ç€ŸäŒæ§ïŒãç²ç¶è ºæ©èœäº¢é²ç/ç²ç¶è ºäžæ¯çãæ¬æ æ§æ¯æŠãä¹³å è¡ç®¡è «ãå¿çæ¢å¡åŸã®ç®¡çãããã³ãã®ä»ã®å¿è¡ç®¡çŸæ£ïŒãæ£è 人å£çµ±èšå¥ïŒå°å ãæäººãé«éœ¢è ïŒãæµéãã£ãã«å¥ïŒç é¢ã®è¬å±ãå°å£²ïŒ è¬å±ããªã³ã©ã€ã³è¬å±ãæ¿åºæ©é¢ããã³æ©é¢ã®äŸçµŠïŒããšã³ããŠãŒã¶ãŒå¥ïŒç é¢ãå°éã¯ãªããã¯ïŒå¿èç ç§ãç¥çµå ç§ãå ... ãã£ãšèŠã
ã ããã·ã³è»èåžå Žã補åã¿ã€ãå¥ïŒ2ïŒ è»èã2ïŒ ã¯ãªãŒã ããã®ä»ã®å±æè£œå€ïŒãçšéå¥ïŒç®èææçæ²»çïŒè¿çç¹ãæ¯å¢çãæ¹¿ç¹é¢é£ææçïŒãåµå·ã±ã¢ïŒåãå·ãæŠãå·ãæè¡éšäœã®ææçïŒãç«å·ããã®ä»ïŒããšã³ããŠãŒã¶ãŒå¥ïŒç é¢ã蚺çæãå°å£²è¬å±ã ãªã³ã©ã€ã³è¬å±ã倿¥èšºçã»ã³ã¿ãŒ)ãæµéãã£ãã«å¥ (ç é¢è¬å±ãå°å£²è¬å±ãé»ååååŒ / ãªã³ã©ã€ã³è¬å±)ãå°çå¥ (åç±³ããšãŒããããã¢ãžã¢å€ªå¹³æŽãã©ãã³ã¢ã¡ãªã«ãäžæ±ãã¢ããªã«)... ãã£ãšèŠã
ã³ã«ãã£ã»ãã»ã·ã³ãã·ã¹ãšã³ã«ãã£ãã¹ã»ããªã¿ãªãŒã¹ã¯ãæ°å€ãã®å¥åº·äžã®å©ç¹ãæã€ãå¯çèçš®ãšæ»ãã ã«ã»ã«ãã©ãŒã§ãã äœãå é€ãå«ãçŽ21ã®ç æ°ã®ããã®åŠçœ®ãšããŠãé«ã䜿çšãããŸãã è¡å§ãçãäŒçµ±çãªäžåœå»åŠããã³ããããã®è¬ã§ã çãã幌è«ã¯ã幌è«ã®äœå ã§æé·ãããããææããè æã®èåã®çµæãšããŠåå£ã«ãã£ãããšåè§£ãããmummifiedãããŸãã åœç¶ã®ããšãªãããã³ã«ãã£ãã¹ã»ã¹ãã ã¯ãã«ã¬ã«ãã©ãŒã®é ããçºå±ããŠããŸããäžççãªã³ã«ãã£ã»ãSinensisãšMilitarisãšãã¹åžå Ž - ã³ãããŠã€ã«ã¹ã®åœ±é¿(COVID-19)ãã³ãããã¯ã³ãããŠã€ã«ã¹(COVID-19)çº... ãã£ãšèŠã
è žããã¹ãšãåŒã°ããè žããã¹ã¯ããµã«ã¢ãã©è žçèïŒSalmonella enterica serotype TyphiïŒã«ãã£ãŠåŒãèµ·ããããçŽ°èææçã§ãããè žããã¹ã¯éåžžãæ±æãããé£ç©ãæ°Žã®æåã«ãã£ãŠåŒãèµ·ãããããè žããã¹ã¯ã¯ãã³ã¯è žããã¹ãäºé²ããè žããã¹ãã身ãå®ããŸããäžçä¿å¥æ©é¢ïŒWHOïŒã¯ã匱æ¯çã¯ã¯ãã³ãè¢èå€ç³äœã¯ã¯ãã³ãçµååã¯ã¯ãã³ã®3çš®é¡ã®è žããã¹ã¯ã¯ãã³ã®äœ¿çšãæšå¥šããŠããã äžçã®è žããã¹ã¯ã¯ãã³åžå Žã¯ã2022幎ã«ã¯3å5,140äžç±³ãã«ãšæšå®ãããäºæž¬æéäžïŒ2022-2030幎ïŒã«12.2 %ã®CAGRã瀺ããšäºæž¬ãããŠããã å³1. è žããã¹ã¯ã¯ã... ãã£ãšèŠã
ã³ãŒãã£ã³ã°é åžå Žãã³ãŒãã£ã³ã°ã¿ã€ãå¥ïŒãã£ã«ã ã³ãŒãã£ã³ã°é ãç³è¡£é ãè žæº¶é ãå§çž®ã³ãŒãã£ã³ã°é ããŒã©ãã³ã³ãŒãã£ã³ã°é ïŒãã³ãŒãã£ã³ã°ææå¥ïŒé«ååã³ãŒãã£ã³ã°ãç³ã³ãŒãã£ã³ã°ãã»ã«ããŒã¹ã³ãŒãã£ã³ã°ãã¢ã¯ãªã«ç³»ã³ãŒãã£ã³ã°ã倩ç¶ã³ãŒãã£ã³ã°ïŒãæ©èœç®çå¥ïŒéæŸæ§ã³ãŒãã£ã³ã°ã é å»¶æŸåºã³ãŒãã£ã³ã°ãåŸæŸæ§/æŸåºå¶åŸ¡ã³ãŒãã£ã³ã°ãå³ãã¹ãã³ã°ã³ãŒãã£ã³ã°ãããã³æ¹¿æ°ããã³å ä¿è·ã³ãŒãã£ã³ã°ïŒãæ²»ççšéå¥ïŒå¿èè¡ç®¡è¬ãèè žè¬ãæææçè¬ãCNSè¬ãé®çè¬ããã¿ãã³ããã³æ é€è£å©é£åããã®ä»ïŒåŒåžåšè¬ãæç³å°¿ç è¬ãªã©ïŒïŒããšã³ããŠãŒã¶ãŒå¥ïŒè£œè¬ã¡ãŒã«ãŒã æ é€è£å©é£åã¡ãŒã«ãŒãåèšè£œé çµç¹ ... ãã£ãšèŠã
çã¯ã¯ãã³åžå Žãã¯ã¯ãã³ã¿ã€ãå¥ïŒæ··åïŒå€äŸ¡ïŒã¯ã¯ãã³ãäžæŽ»åïŒäžæŽ»åïŒã¯ã¯ãã³ã匱æ¯åçã¯ã¯ãã³ãçµæãã¯ã¯ãã³ããããœã€ãã¯ã¯ãã³ãDNA/ãã¯ã¿ãŒããŒã¹ã¯ã¯ãã³ïŒãçŸæ£é©å¿çå¥ïŒãŠã·åŒåžåšçŸæ£ïŒBRDè€åäœãIBRãBRSVãPI3ïŒãå£è¹ç«ïŒFMDïŒãã¯ãã¹ããªãžãŠã çŸæ£ïŒé»èç ãè žæ¯çŽ è¡çã ç Žå·é¢šïŒããŠã·ãŠã€ã«ã¹æ§äžç¢ïŒBVDïŒãã¬ããã¹ãã©çãä¹³æ¿çããã«ã»ã©çãççœç ããã®ä»ïŒãšãŒãç ããã«ãŒã¿ã³ã°ãªã©ïŒïŒãçã®çš®é¡å¥ïŒä¹³çãèçãç¹æ®çãããã³åç/è¥ãçïŒãæäžçµè·¯å¥ïŒæ³šå°ã¯ã¯ãã³ãçµéŒ»ã¯ã¯ãã³ãçµå£ã¯ã¯ãã³ïŒããšã³ããŠãŒã¶ãŒå¥ïŒåçšïŒ é ªèŸ²å Žãé€çå Žãšç§å Žãåç©ç é¢ãšç é¢... ãã£ãšèŠã
å»çã®é£äºã¯ãæ§ã ãªç æ°ã«èŠããã§ããäººãæ²»ãå¯äžã®ç®çã®ããã«äœãããã«ã¹ã¿ã ã¡ã€ãã®æ¶²äœãœãªã¥ãŒã·ã§ã³ã§ãã æ§ã ãªç æ°ã«èŠãã人ã ã«ãã¶ã€ã³ãããé£äºãæäŸããŸãã ååãªæ é€çŽ ãæ£è ã«æäŸããç¹å¥ã«æºåãããé£äºçæ³ã§ãã å°å æ é€ãšç£çãã代è¬ã®èª€ããæ²»çããããã«ãå»åŠçé£äºãäœæãããŸããããŸããŸãªææšã®ããã®å€æ§ãªè£œåããŒããã©ãªãªãæã€Abbottãªã©ã®äŒæ¥ã¯ãå»çé£ååžå Žããã£ããææ¡ããå€ãã®äºæ¥é åãéããŠäžè²«ããåçãçæã§ããŸãã ã¡ãŒã«ãŒã¯ãæ°ããç æ°ã®é©å¿ã®ããã®è£œåãéçºããŠããŸãã, å»çé£ååžå Žã®çææé·. å»çé£åã¯ãç¹å®ã®ç æ°ã«èŠãã人ã ã®æ é€ãšä»£è¬ã®... ãã£ãšèŠã
ãã©ã³ãŒãæ²»çåžå Žãæ²»çã¿ã€ãå¥ïŒæçç©è³ªïŒçµå£æçç©è³ªããã³å±ææçç©è³ªïŒãå€ç§çåŠçœ®ïŒãã©ã³ãŒãæ§ç«æ¯çïŒTTïŒæè¡ããŸã€ãé€å»ïŒè±æ¯ãªã©ïŒïŒãé¡ã®æž æœãšè¡çïŒè¡çãããããã³å ¬è¡è¡çãã£ã³ããŒã³ïŒïŒã補å€å¥ïŒçµå£é å€ãçµå£æžæ¿æ¶²ãå±æïŒ è»èãæ³šå°å€ãããã³åŸæŸæ§/çŒçšã€ã³ãµãŒãïŒç ç©¶éçºæ®µéïŒïŒããšã³ããŠãŒã¶ãŒå¥ïŒç é¢ã蚺çæãè¬å±ãå ¬è¡è¡çæ©é¢ïŒãçŸæ£æ®µéå¥ïŒæŽ»åæ§ãã©ã³ãŒãããã©ã³ãŒãæ§ç«æ¯çãç¢çæ§ç¢çïŒãæµéãã£ãã«å¥ïŒãªã³ã©ã€ã³ããã³ãªãã©ã€ã³ïŒãå°çå¥ïŒåç±³ããšãŒããããã¢ãžã¢å€ªå¹³æŽãã©ãã³ã¢ã¡ãªã«ãäžæ±ãã¢ããªã«ïŒ... ãã£ãšèŠã
å€åœ¢æ§é¢ç¯çãšãåŒã°ãããªã¹ããªã¢ã«ãããã¯ãé¢ç¯çã®æãäžè¬çãªåœ¢æ ã§ãã äœå ã®æ§ã ãªé¢ç¯ã«åœ±é¿ããŸãã ããããç æ°ã¯èãéŠãè °ãè °ãæã®å°ããªé¢ç¯ã«å€§ããªåœ±é¿ãäžããŸãã Osteoarthritisã¯ãé¢ç¯çŸæ£ã®äž»èŠãªè¡°åŒ±åœ¢æ ã§ãããããæ¶å管ã®äººå£ã§æããã§ãã ç æ°ã¯äœäœååŠçããã»ã¹ã§ãããçæŽ»ã®è³ªãæ©èœã®åªå€±ãããã³é床ã®çã¿ã«é©åºŠã«ã€ãªãããç¹ã«äœäœæŽ»åãé«äœè³ªéææ°(BMI)ãæã€äººå£ã§ã Osteoarthritisã¯è»éªšã®å±æçãªæå€±ã«ãã£ãŠç çåŠçã«ç¹åŸŽä»ããããŸãã飿¥ãã骚ããã³é¢é£ã®ççã®æ¹é ã æ§ã ãªãã©ãŠãã¯ãé¢ç¯ã®å¿ èŠæ§ãããªã¬ãŒããŠä¿®åŸ©ããããšãã§ããŸ... ãã£ãšèŠã
ãã»ããŠç åžå ŽãçŸæ£ã¿ã€ãå¥ïŒé¡æ§ãã»ããŠç ããã³æœåšæ§ãã»ããŠç ïŒãçç¶å¥ïŒç²ç¶è ºäžæ¯çããã»ããŠçŒçª©çïŒçŒïŒãç®èé害ïŒåèéªšç²æ¶²æ°Žè «ïŒããã®ä»ã®å šèº«çç¶ïŒãèšºææ¹æ³å¥ïŒèšåºè©äŸ¡ãç»å蚺æïŒè¶ 鳿³¢ãæŸå°æ§ãšãŠçŽ åã蟌ã¿ã¹ãã£ã³ãMRI/CTïŒïŒ çŒçª©çŸæ£))ãæ€æ»å®€(TSHãéé¢T3/éé¢T4ãTSHåå®¹äœæäœ(TRAb)))ãæ²»çæ³å¥(è¬çåŠç(æç²ç¶è ºè¬(ã¡ãããŸãŒã«ããããã«ããªãŠã©ã·ã«ãã«ã«ãããŸãŒã«)ãÎ²é®æè¬ãã³ã«ãã³ã¹ããã€ããå ç«æå¶è¬)ãæŸå°æ§ãšãŠçŽ çæ³ãå€ç§ç(ç²ç¶è ºå šæè¡) ããã³ç²ç¶è ºäºå šæè¡ïŒãè£å©ç/çŒç§ïŒçŒçª©æžå§è¡ããªããã·ãããããã³ããããã ããïŒãããã³... ãã£ãšèŠã